News

Joe Mansueto's MORN May Drip: 35 Sales, Still Owns 37.5%

Morningstar founder Joe Mansueto filed 35 Form 4 sales in the first 12 days of May 2026, draining about $5 million at $176-180 per share. The drip is programmatic. His 37.5% beneficial stake is untouched.

By , Breaking News Editor
PublishedUpdated

Joseph Mansueto, the founder of Morningstar and one of the longest-tenured 13F-disclosed insider sellers in our database, filed 35 separate Form 4 sales in the first twelve calendar days of May 2026. The transactions hit at $176-180 per share in incremental clips ranging from 18 shares to roughly 7,200, totaling around $5 million in proceeds. The drip pattern is so consistent that it reads as a prearranged plan, not a discretionary directional view.

What makes the filings noteworthy is what they don't change. The latest Mansueto Schedule 13G/A on file (dated February 12, 2026) reports a 37.5% beneficial stake — 14,909,759 shares — and the May trickle does not visibly dent that. Joseph Mansueto remains, by a wide margin, the largest single beneficial owner of Morningstar.

The drip, by the numbers

From May 7 through May 12, 2026, the Form 4 sequence ran continuously across six trading days. The deepest single day was May 11 with a 7,232-share sale at $175.96 alongside several smaller clips. Average daily proceeds across the window were under $1 million, and the largest individual ticket was a $1.3 million block. Every transaction carried the same code (S, open-market sale). The latest filing accession, 0001324069-26-000024, was submitted on May 12, 2026.

For context, Mansueto's career sells total $1.95 billion across 11,077 individual transactions since 2006. The pacing has been remarkably steady. The current pattern — daily small-lot sales clustered into multi-week windows — has run continuously for years and is the canonical example of disciplined founder monetization through equity programs rather than discretionary timing.

The 13G picture is unchanged

Morningstar carries an unusually concentrated insider register. Two filings make this explicit:

  • Mansueto Joseph D: 37.5% beneficial owner / 14,909,759 shares (Schedule 13G/A, February 12, 2026).
  • Daniel Mansueto: 9.5% beneficial owner / 3,757,306 shares (Schedule 13G/A, February 12, 2026).

Together those two filings cover roughly 47% of Morningstar's outstanding stock. The May 2026 Form 4 sales — even cumulatively across an entire year of similar pacing — are mathematically incapable of moving the founder's stake below the SEC's 5% reporting threshold within any near-term window. This is not a position exit. It is a controlled liquidation against a position that, on the public 13G record, is still extraordinarily large.

What the institutional roster says about the float

Because the Mansueto family controls almost half the company, the institutional 13F record is reading on a structurally narrow public float. The top five institutional holders per the most recent quarterly data:

BlackRock and Morgan Stanley at the top are largely index-tracking and prime-brokerage inventory; Select Equity and BAMCO (Ron Baron's growth shop) are conviction-driven active mandates. The active component of the holder base is where any reaction to the founder's selling cadence will surface first.

What to watch next

Three specific anchors define the window:

  1. Next Form 4 sequence break. If the daily filings pause for more than five consecutive trading days, the plan window has closed or been amended. The watch dates are the May 19 and May 26 weeks.
  2. Next Schedule 13G/A refresh. The next mandatory amendment is the February 2027 annual filing, but a voluntary refresh can appear sooner if the family stake crosses a 1% reporting trigger. Track the SEC filing index under accession prefix 0001324069-.
  3. Morningstar's next earnings release, which will set the next valuation reference for the sales window. The active institutional positions held by Select Equity and Baron Capital's BAMCO arm will be the first 13F lines to move if the founder's pacing changes interpretation.

Why this isn't a sentiment signal

It is tempting to read a 35-trade May window as a directional bet by the founder. The data argues otherwise. Career sell totals of $1.95 billion accumulated over 19 years and 11,077 individual filings describe a pattern, not a series of discrete bearish decisions. The same per-share price range (~$170-180), the same small-lot structure, and the same accession-number cadence appear in 2024 and 2025 windows on the same insider profile. Mansueto's pattern looks like the programmatic liquidation a founder runs against a 37.5% beneficial stake — visible, scheduled, and orthogonal to short-horizon stock view.

For broader signal context across all insiders and 13D/G filers we cover, see the aggregate insights feed.

FAQ

Why is Joe Mansueto selling Morningstar shares?

The May 2026 drip looks programmatic — small-lot daily sales at consistent price ranges, identical to multi-year prior patterns. This is consistent with a prearranged plan-driven liquidation against his roughly 37.5% beneficial stake, not a discretionary directional view.

How much of Morningstar does Joe Mansueto still own?

Per the most recent Schedule 13G/A dated February 12, 2026, Mansueto remains a 37.5% beneficial owner with 14,909,759 shares. Together with Daniel Mansueto's 9.5% stake, the family controls roughly 47% of MORN.

How many Form 4 sales has Mansueto filed in May 2026?

35 sales across May 7-12, 2026, in incremental clips ranging from 18 shares to roughly 7,200 shares at prices between $176 and $180. The latest accession is 0001324069-26-000024 filed May 12, 2026.

Alex RiveraBreaking News Editor

Breaking News Editor at 13F Insight. First to report on major SEC filings, institutional moves, and regulatory developments.

More from Alex